Recurrent Miscarriage: Diabetes Drug could lead to New Treatment

An existing drug can be used to improve the womb for pregnancy, study led by University of Warwick finds Sitagliptin is first drug of its kind shown to increase stem cells in the lining of the womb Stem cells have been shown to improve renewal of the womb lining and to reduce inflammation in early […]

Read More… from Recurrent Miscarriage: Diabetes Drug could lead to New Treatment

Diabetes – The Facts

Diabetes – the facts   One in 15 people in the UK have diabetes. This includes one million people who have Type 2 but haven’t yet been diagnosed. In the UK, someone is diagnosed with diabetes every two minutes.  Worldwide  According to the World Health Organization (WHO), there are around 422 million people are living with diabetes worldwide. […]

Read More… from Diabetes – The Facts

Shift work increases diabetes and heart disease risk

With over 20% of the population in industrial countries engaging shift work – in sectors such as healthcare and transportation – we urgently need to understand its health burden . Many studies have shown that shift work is associated with heart and metabolic diseases, but new research in Experimental Physiology has clarified how shift work […]

Read More… from Shift work increases diabetes and heart disease risk

Understanding type 2 diabetes in Malawi

Researchers at the University of Glasgow are collaborating with Malawian scientists to try to find out why some people in Malawi develop type 2 diabetes – even though many are slim and highly active. Worldwide, diabetes is on the rise with almost 400 million people living with the disease – a figure that is predicted […]

Read More… from Understanding type 2 diabetes in Malawi

Popular diabetes drug may not reduce risk of death

One class of drug used to treat type 2 diabetes may not reduce the risk of death when compared with placebo, suggests new findings. But two other commonly prescribed drugs do significantly reduce mortality and could perhaps be better options. The research, led by scientists from Imperial College London and published in the Journal of […]

Read More… from Popular diabetes drug may not reduce risk of death

Diabetes UK Professional Conference

At the Diabetes UK Professional Conference, which takes place this week, health workers, doctors, nurses and researchers will join with policy makers and business leaders to look at the major issues which will make a difference to how we combat this condition in future. The number of people with type 2 diabetes has doubled in […]

Read More… from Diabetes UK Professional Conference

Can diabetes drug really protect the heart?

More work needs to be done to examine the real world effects of the commonly prescribed diabetes drug empagliflozin, new research in the journal Diabetes Therapy finds. Examining data from over 60,000 patients with type 2 diabetes, researchers from the University of Surrey discovered that the highly-publicised cardiovascular benefits of the popular diabetes drug empagliflozin […]

Read More… from Can diabetes drug really protect the heart?

Should you go vegan?

Becoming a vegan – eating only plant-based foods – is a personal choice that is often driven by the desire to feel healthier, as well as showing support for animal welfare. Today more and more celebrities are following the vegan trend, but is this really the way to go? Let’s take a look at the […]

Read More… from Should you go vegan?

Do you have prediabetes?

Britain is facing a Type 2 diabetes epidemic of unprecedented proportions. Around seven million adults in the UK are estimated to have prediabetes without realising it – putting them a 50 per cent chance of developing full-blown diabetes within ten years. So what it Prediabetes? Prediabetes is not a medical condition in itself – and there […]

Read More… from Do you have prediabetes?

Don’t overlook Type 3c diabetes

pancreas

The health of people with diabetes is being put at risk due to the failure of doctors to recognise an important subtype of diabetes which is known as Type 3c, according to a  new study in the journal Diabetes Care. In the first ever study of its kind, researchers from the University of Surrey, examined the […]

Read More… from Don’t overlook Type 3c diabetes